1 Lanreotide Market Overview 1.1 Product Overview and Scope of Lanreotide 1.2 Lanreotide Segment by Type 1.2.1 Global Lanreotide Sales Growth Rate Comparison by Type (2020-2026) 1.2.2 60 mg 1.2.3 90 mg 1.2.4 120 mg 1.3 Lanreotide Segment by Application 1.3.1 Lanreotide Sales Comparison by Application: (2020-2026) 1.3.2 Hospital 1.3.3 Pharmacy 1.4 Global Lanreotide Market Size Estimates and Forecasts 1.4.1 Global Lanreotide Revenue 2015-2026 1.4.2 Global Lanreotide Sales 2015-2026 1.4.3 Lanreotide Market Size by Region: 2020 Versus 2026 2 Global Lanreotide Market Competition by Manufacturers 2.1 Global Lanreotide Sales Market Share by Manufacturers (2015-2020) 2.2 Global Lanreotide Revenue Share by Manufacturers (2015-2020) 2.3 Global Lanreotide Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Lanreotide Manufacturing Sites, Area Served, Product Type 2.5 Lanreotide Market Competitive Situation and Trends 2.5.1 Lanreotide Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Lanreotide Players (Opinion Leaders) 3 Lanreotide Retrospective Market Scenario by Region 3.1 Global Lanreotide Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Lanreotide Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Lanreotide Market Facts & Figures by Country 3.3.1 North America Lanreotide Sales by Country 3.3.2 North America Lanreotide Sales by Country 3.3.3 the United States 3.3.4 Canada 3.4 Europe Lanreotide Market Facts & Figures by Country 3.4.1 Europe Lanreotide Sales by Country 3.4.2 Europe Lanreotide Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 UK 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Lanreotide Market Facts & Figures by Region 3.5.1 Asia Pacific Lanreotide Sales by Region 3.5.2 Asia Pacific Lanreotide Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Lanreotide Market Facts & Figures by Country 3.6.1 Latin America Lanreotide Sales by Country 3.6.2 Latin America Lanreotide Sales by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Lanreotide Market Facts & Figures by Country 3.7.1 Middle East and Africa Lanreotide Sales by Country 3.7.2 Middle East and Africa Lanreotide Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Lanreotide Historic Market Analysis by Type 4.1 Global Lanreotide Sales Market Share by Type (2015-2020) 4.2 Global Lanreotide Revenue Market Share by Type (2015-2020) 4.3 Global Lanreotide Price Market Share by Type (2015-2020) 4.4 Global Lanreotide Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Lanreotide Historic Market Analysis by Application 5.1 Global Lanreotide Sales Market Share by Application (2015-2020) 5.2 Global Lanreotide Revenue Market Share by Application (2015-2020) 5.3 Global Lanreotide Price by Application (2015-2020) 6 Company Profiles and Key Figures in Lanreotide Business 6.1 IPSEN 6.1.1 Corporation Information 6.1.2 IPSEN Description, Business Overview 6.1.3 IPSEN Lanreotide Sales, Revenue and Gross Margin (2015-2020) 6.1.4 IPSEN Products Offered 6.1.5 IPSEN Recent Development 7 Lanreotide Manufacturing Cost Analysis 7.1 Lanreotide Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Lanreotide 7.4 Lanreotide Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Lanreotide Distributors List 8.3 Lanreotide Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Lanreotide Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Lanreotide by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Lanreotide by Type (2021-2026) 10.2 Lanreotide Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Lanreotide by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Lanreotide by Application (2021-2026) 10.3 Lanreotide Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Lanreotide by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Lanreotide by Region (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Lanreotide Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Lanreotide Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Lanreotide Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Lanreotide Manufacturers Covered in This Study Table 5. Global Lanreotide Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Lanreotide Sales Share by Manufacturers (2015-2020) Table 7. Global Lanreotide Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Lanreotide Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Lanreotide Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Lanreotide Sales Sites and Area Served Table 11. Manufacturers Lanreotide Product Types Table 12. Global Lanreotide Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Lanreotide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lanreotide as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Lanreotide Players Table 16. Global Lanreotide Sales (K Units) by Region (2015-2020) Table 17. Global Lanreotide Sales Market Share by Region (2015-2020) Table 18. Global Lanreotide Revenue (Million US$) by Region (2015-2020) Table 19. Global Lanreotide Revenue Market Share by Region (2015-2020) Table 20. North America Lanreotide Sales by Country (2015-2020) (K Units) Table 21. North America Lanreotide Sales Market Share by Country (2015-2020) Table 22. North America Lanreotide Revenue by Country (2015-2020) (US$ Million) Table 23. North America Lanreotide Revenue Market Share by Country (2015-2020) Table 24. Europe Lanreotide Sales by Country (2015-2020) (K Units) Table 25. Europe Lanreotide Sales Market Share by Country (2015-2020) Table 26. Europe Lanreotide Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Lanreotide Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Lanreotide Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Lanreotide Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Lanreotide Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Lanreotide Revenue Market Share by Region (2015-2020) Table 32. Latin America Lanreotide Sales by Country (2015-2020) (K Units) Table 33. Latin America Lanreotide Sales Market Share by Country (2015-2020) Table 34. Latin America Lanreotide Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Lanreotide Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Lanreotide Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Lanreotide Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Lanreotide Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Lanreotide Revenue Market Share by Country (2015-2020) Table 40. Global Lanreotide Sales (K Units) by Type (2015-2020) Table 41. Global Lanreotide Sales Share by Type (2015-2020) Table 42. Global Lanreotide Revenue (Million US$) by Type (2015-2020) Table 43. Global Lanreotide Revenue Share by Type (2015-2020) Table 44. Global Lanreotide Price (USD/Unit) by Type (2015-2020) Table 45. Global Lanreotide Sales (K Units) by Application (2015-2020) Table 46. Global Lanreotide Sales Market Share by Application (2015-2020) Table 47. Global Lanreotide Sales Growth Rate by Application (2015-2020) Table 48. IPSEN Corporation Information Table 49. IPSEN Description and Business Overview Table 50. IPSEN Lanreotide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. IPSEN Main Product Table 52. IPSEN Recent Development Table 53. Production Base and Market Concentration Rate of Raw Material Table 54. Key Suppliers of Raw Materials Table 55. Lanreotide Distributors List Table 56. Lanreotide Customers List Table 57. Lanreotide Market Trends Table 58. Lanreotide Opportunities and Drivers Table 59. Lanreotide Market Challenges Table 60. Global Lanreotide Sales (K Units) Forecast by Type (2021-2026) Table 61. Global Lanreotide Sales Market Share Forecast by Type (2021-2026) Table 62. Global Lanreotide Revenue (Million US$) Forecast by Type (2021-2026) Table 63. Global Lanreotide Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 64. Global Lanreotide Sales (K Units) Forecast by Application (2021-2026) Table 65. Global Lanreotide Revenue (Million US$) Forecast by Application (2021-2026) Table 66. Global Lanreotide Sales (K Units) Forecast by Region (2021-2026) Table 67. Global Lanreotide Sales Market Share Forecast by Region (2021-2026) Table 68. Global Lanreotide Revenue Forecast by Region (2021-2026) (US$ Million) Table 69. Global Lanreotide Revenue Market Share Forecast by Region (2021-2026) Table 70. Research Programs/Design for This Report Table 71. Key Data Information from Secondary Sources Table 72. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Lanreotide Figure 2. Global Lanreotide Sales Market Share by Type: 2020 VS 2026 Figure 3. 60 mg Product Picture Figure 4. 90 mg Product Picture Figure 5. 120 mg Product Picture Figure 6. Global Lanreotide Consumption Market Share by Application: 2020 VS 2026 Figure 7. Hospital Figure 8. Pharmacy Figure 9. Global Lanreotide Market Size 2015-2026 (US$ Million) Figure 10. Global Lanreotide Sales Capacity (K Units) (2015-2026) Figure 11. Global Lanreotide Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Lanreotide Sales Share by Manufacturers in 2020 Figure 13. Global Lanreotide Revenue Share by Manufacturers in 2019 Figure 14. The Global 5 and 10 Largest Players: Market Share by Lanreotide Revenue in 2019 Figure 15. Lanreotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 16. Global Lanreotide Sales Market Share by Region (2015-2020) Figure 17. Global Lanreotide Sales Market Share by Region in 2019 Figure 18. Global Lanreotide Revenue Market Share by Region (2015-2020) Figure 19. Global Lanreotide Revenue Market Share by Region in 2019 Figure 20. North America Lanreotide Sales Market Share by Country in 2019 Figure 21. North America Lanreotide Revenue Market Share by Country in 2019 Figure 22. the United States Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 23. the United States Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 24. Canada Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 25. Canada Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Europe Lanreotide Sales Market Share by Country in 2019 Figure 27. Europe Lanreotide Revenue Market Share by Country in 2019 Figure 28. Germany Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 29. Germany Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. France Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 31. France Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. UK Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 33. UK Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Italy Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 35. Italy Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Russia Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 37. Russia Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Asia Pacific Lanreotide Sales Market Share by Region in 2019 Figure 39. Asia Pacific Lanreotide Revenue Market Share by Region in 2019 Figure 40. China Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 41. China Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Japan Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 43. Japan Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. South Korea Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 45. South Korea Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. India Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 47. India Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Australia Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 49. Australia Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Taiwan Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 51. Taiwan Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Indonesia Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 53. Indonesia Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Thailand Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 55. Thailand Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Malaysia Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 57. Malaysia Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Philippines Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 59. Philippines Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Vietnam Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 61. Vietnam Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Latin America Lanreotide Sales Market Share by Country in 2019 Figure 63. Latin America Lanreotide Revenue Market Share by Country in 2019 Figure 64. Mexico Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 65. Mexico Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Brazil Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 67. Brazil Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Argentina Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 69. Argentina Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Middle East and Africa Lanreotide Sales Market Share by Country in 2019 Figure 71. Middle East and Africa Lanreotide Revenue Market Share by Country in 2019 Figure 72. Turkey Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 73. Turkey Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Saudi Arabia Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 75. Saudi Arabia Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. UAE Lanreotide Sales Growth Rate (2015-2020) (K Units) Figure 77. UAE Lanreotide Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Sales Market Share of Lanreotide by Type (2015-2020) Figure 79. Sales Market Share of Lanreotide by Type in 2020 Figure 80. Global Lanreotide Market Share by Price Range (2015-2020) Figure 81. Revenue Market Share of Lanreotide by Type in 2019 Figure 82. Global Lanreotide Sales Growth by Type (2015-2020) (K Units) Figure 83. Sales Market Share of Lanreotide by Application (2015-2020) Figure 84. Sales Market Share of Lanreotide by Application in 2020 Figure 85. Revenue Share of Lanreotide by Application (2015-2020) Figure 86. Revenue Share of Lanreotide by Application in 2020 Figure 87. Key Raw Materials Price Trend Figure 88. Manufacturing Cost Structure of Lanreotide Figure 89. Manufacturing Process Analysis of Lanreotide Figure 90. Lanreotide Industrial Chain Analysis Figure 91. Channels of Distribution Figure 92. Distributors Profiles Figure 93. Porter's Five Forces Analysis Figure 94. Bottom-up and Top-down Approaches for This Report Figure 95. Data Triangulation Figure 96. Key Executives Interviewed

IPSEN